Follow‐up magnetic resonance imaging/3D‐magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Summary: Background: In patients with primary sclerosing cholangitis follow‐up magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP) is performed by many centres, particularly for the early detection of biliary malignancies and strictures. Clinically meaningful MRI‐based definitions of primary sclerosing cholangitis related complications are, however, lacking. Aim: To investigate how primary sclerosing cholangitis experts interpret follow‐up MRI/MRCP with a focus on conclusions that may impact clinical decision‐making in primary sclerosing cholangitis. Methods: Within the International Primary Sclerosing Cholangitis Study Group, an online survey on 16 real‐life primary sclerosing cholangitis cases including clinical and biochemical information as well as a T2‐weighted liver MRI/3D‐MRCP was conducted. The interpretation of images and subsequent recommendations were assessed using a multiple‐choice questionnaire. An inter‐rater reliability calculation (Fleiss′ kappa) was performed and factors potentially affecting the interpretation of magnetic resonance images were analysed using generalised linear mixed‐effect models. Results: Forty‐four members/associates of the International Primary Sclerosing Cholangitis Study Group (median experience in the care of primary sclerosing cholangitis patients: 14 years) completed the survey. The MRI interpretation significantly varied among the participants. The lowest agreement was found with respect to the indication to perform subsequent endoscopic retrograde cholangiopancreatography (ERCP; Κ = 0.12, 95%CI 0.11‐0.14). Elevated total bilirubin was the variable with the strongest effect on the rate of suspected dominant strictures, cholangiocarcinoma or ERCP recommendations. Liver cirrhosis did not prevent participants from recommending ERCP. Overall, the survey participants′ recommendations contrasted the real‐life management and outcome. Conclusions: In primary sclerosing cholangitis, the interpretation of follow‐up MRI/3D‐MRCP significantly varies even among experts and seems to be primarily affected by bilirubin levels. Generally accepted MRI‐based definitions of primary sclerosing cholangitis‐related complications are urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
Boonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W. M., Poen, A. C., van Nieuwkerk, K. M., Drenth, J. P., Witteman, B. J., Tuynman, H. A., et al. (2013) · Hepatology · doi:10.1002/hep.26565 · Cited by 725 · cited 4×
“This questionnaire assessed the survey participant0s overall MRI/3D-MRCP interpretation (1), the presence of bile duct changes (2), the presence of dominant strictures (3), the presence of CCA (4), whether ERCP should be performed (5) and arguments for/ against ERCP recommendation (6).”
BackgroundInfluentialEpidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
Boonstra, K., Beuers, U., & Ponsioen, C. Y. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.025 · Cited by 632
ACG clinical guideline: primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., & Harrison, E. M. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.112 · Cited by 524
Aabakken, L., Karlsen, T., Albert, J., Arvanitakis, M., Chazouilleres, O., Dumonceau, J.-M., Färkkilä, M., Fickert, P., Hirschfield, G., Laghi, A., et al. (2017) · Endoscopy · doi:10.1055/s-0043-107029 · Cited by 255
Self-citationSurveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis
Ali, A. H., Tabibian, J. H., Nasser‐Ghodsi, N., Lennon, R. J., DeLeon, T., Borad, M. J., Hilscher, M., Silveira, M. G., Carey, E. J., & Lindor, K. D. (2018) · Hepatology · doi:10.1002/hep.29730 · Cited by 140 · cited 2×
“Within this cohort the median clinical experience in the care of PSC patients was 14 (7-20) years.”
BackgroundAabakken, L., Karlsen, T. H., Albert, J., Arvanitakis, M., Chazouilleres, O., Dumonceau, J.-M., Färkkilä, M., Fickert, P., Hirschfield, G. M., Laghi, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.013 · Cited by 107
Self-citation
Cited by
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., et al. (2023) · Hepatology · doi:10.1002/hep.32771 · Cited by 428
Lemoinne, S., Cazzagon, N., El Mouhadi, S., Trivedi, P. J., Dohan, A., Kemgang, A., Ben Belkacem, K., Housset, C., Chretien, Y., Corpechot, C., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.03.013 · Cited by 78
Grigoriadis, A., Ringe, K. I., Andersson, M., Kartalis, N., & Bergquist, A. (2021) · European Journal of Radiology · doi:10.1016/j.ejrad.2021.109884 · Cited by 43
Magnetic resonance imaging features of small-duct primary sclerosing cholangitis
Kozaka, K., Sheedy, S. P., Eaton, J. E., Venkatesh, S. K., & Heiken, J. P. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02572-w · Cited by 17
“Furthermore, the accuracy of diagnosing PSC with MRCP has been reported to be inconsistent even among experienced PSC experts [28].”
BackgroundWannhoff, A., Brune, M., Knierim, J., Weiss, K. H., Rupp, C., & Gotthardt, D. N. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15146 · Cited by 17
“As follow‐up imaging in PSC, it has been shown interpretation of magnetic resonance cholangiography remains challenging even among experts.(14) Biliary malignancy is associated with increased serum levels of CA19‐9 and thus might be used to screen for BTC in patients with PSC.”
Background
Metadata
- Authors
- Zenouzi, R., Liwinski, T., Yamamura, J., Weiler‐Normann, C., Sebode, M., Keller, S., Lohse, A. W., Schramm, C., & the International PSC Study Group (IPSCSG)
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2018-05-09
- Volume
- 48
- Issue
- 2
- Pages
- 169-178
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2799994741
- Cited by
- 49
- References
- 8
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.